Zach Berman

Dr. Zach Berman, an interventional radiologist from UC San Diego, and Dr. Tyler Sandow from Ochsner Health share their expertise on Y90 dose optimization strategies for liver cancer. They discuss the delicate balance of targeting tumors while preserving healthy liver tissue. The doctors delve into real-world cases, analyzing lab values that affect treatment decisions, strategies for managing portal vein invasion, and the complexities of large tumors. Their insights highlight the importance of a multidisciplinary approach to maximize patient outcomes.

Dr. Tyler Sandow and Dr. Zach Berman, both interventional radiologists, dive into the complexities of treating metastatic diseases with Y90. They discuss the types of metastases they handle and how Y90 can alleviate tumor-related pain. Key topics include the differences between liver-dominant and liver-only conditions, advanced dosing techniques, and the significance of mutation status in treatment. They also share compelling case studies to highlight the decision-making process for various treatment strategies, ensuring improved patient outcomes.